Both CPAP and BiPAP significantly improve executive function and sleep quality in OHS patients, with BiPAP providing additional memory benefits, though results should be interpreted as hypothesis-generating given the small sample size.
Key Findings
Results
Executive function improved significantly in both CPAP and BiPAP treatment groups, as measured by Stroop task accuracy.
Stroop task accuracy increased greater than 20% in both treatment groups (p < 0.005)
The study used a prospective, randomized design with 24 OHS patients
Treatment duration was 2 months of positive airway pressure therapy
Stroop task accuracy change from baseline was a primary outcome measure
Results
Sleep quality improved substantially in both treatment groups as measured by the Pittsburgh Sleep Quality Index (PSQI).
CPAP group: PSQI decreased by 6.63 points (p < 0.05)
BiPAP group: PSQI decreased by 5.08 points (p < 0.05)
PSQI score change from baseline was a co-primary outcome measure
Sleep quality was also assessed using the Epworth Sleepiness Scale (ESS)
Results
BiPAP demonstrated superior benefits for logical memory compared to CPAP.
The difference in logical memory improvement between BiPAP and CPAP was statistically significant (p < 0.05)
This finding was not observed for other cognitive domains tested
Comprehensive neuropsychological testing included psychomotor vigilance, flanker, and Stroop tasks in addition to memory assessment
Results
Psychomotor vigilance and flanker task performance showed no significant changes in either the CPAP or BiPAP treatment group.
Neither CPAP nor BiPAP produced statistically significant improvements in psychomotor vigilance task performance
Neither CPAP nor BiPAP produced statistically significant improvements in flanker task performance
These tasks assess attention and response inhibition domains distinct from executive function and memory
Methods
The study enrolled 24 OHS patients in a prospective, randomized design with a non-randomized control group.
Patients were randomly allocated to CPAP or BiPAP therapy in a 1:1 ratio (12 per group)
Patients who declined treatment formed a non-randomized control group
Objective compliance monitoring was performed using device-recorded data
The authors explicitly note results 'should be interpreted as hypothesis-generating' given the small sample size
Treatment duration was 2 months
Background
OHS causes significant neurocognitive dysfunction through chronic hypercapnia and sleep disruption, and the comparative cognitive effects of CPAP versus BiPAP had remained unclear prior to this study.
Both CPAP and BiPAP are established treatments for the respiratory symptoms of OHS
Chronic hypercapnia and sleep disruption are identified as the primary mechanisms underlying neurocognitive dysfunction in OHS
The comparative cognitive outcomes of the two therapies had not been clearly established
What This Means
This research suggests that treating obesity hypoventilation syndrome (OHS) — a condition where excess body weight causes breathing problems during sleep, leading to high carbon dioxide levels — with breathing support machines can meaningfully improve brain function and sleep quality. OHS patients who used either CPAP (which delivers continuous air pressure) or BiPAP (which adjusts pressure for inhaling and exhaling) for two months showed dramatic improvements in their ability to perform tasks requiring focus and mental control, with accuracy on a key cognitive test rising by more than 20%. Both groups also reported substantially better sleep quality.
One notable difference emerged between the two devices: BiPAP appeared to provide additional benefits for memory — specifically logical memory — compared to CPAP. However, not all aspects of thinking improved; tests measuring sustained attention and the ability to ignore distractions showed no significant change in either group after treatment. This suggests that breathing therapy may help some cognitive domains more than others in OHS patients.
This research involved only 24 patients, and the authors themselves caution that the findings should be considered preliminary and hypothesis-generating rather than definitive. The study is an important early step in understanding whether the choice between CPAP and BiPAP should take into account potential effects on thinking and memory, not just breathing. Larger studies would be needed to confirm these patterns and guide clinical decisions.
Check Your Own Numbers
Upload your bloodwork. We'll cross-reference your results against this study and 4,700 others.
Kung S, Shen Y, Wang H, Chang E. (2026). Investigating the effects of CPAP/BiPAP therapy on cognitive function and reaction time in patients with obesity hypoventilation syndrome.. Respiratory physiology & neurobiology. https://doi.org/10.1016/j.resp.2026.104589